Home » Stocks » InspireMD

InspireMD Inc. (NSPR)

Stock Price: $0.423 USD -0.007 (-1.52%)
Updated Aug 14, 2020 2:44 PM EDT - Market open

Stock Price Chart

Key Info

Market Cap 6.47M
Revenue (ttm) 4.34M
Net Income (ttm) -9.09M
Shares Out 33.36M
EPS (ttm) -2.90
PE Ratio n/a
Forward PE 11.70
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 14, 2020
Last Price $0.423
Previous Close $0.429
Change ($) -0.007
Change (%) -1.52%
Day's Open 0.420
Day's Range 0.417 - 0.428
Day's Volume 592,758
52-Week Range 0.386 - 5.300

More Stats

Market Cap 6.47M
Enterprise Value 6.94M
Earnings Date (est) Nov 17, 2020
Ex-Dividend Date n/a
Shares Outstanding 33.36M
Float 4.31M
EPS (basic) -0.9
EPS (diluted) -2.90
FCF / Share -0.58
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 185,348
Short Ratio 0.07
Short % of Float 0.56%
Beta 2.21
PE Ratio n/a
Forward PE 11.70
P/FCF Ratio n/a
PS Ratio 1.49
PB Ratio 1.16
Revenue 4.34M
Operating Income -8.97M
Net Income -9.09M
Free Cash Flow -7.38M
Net Cash -476,000
Net Cash / Share -0.03
Gross Margin 17.42%
Operating Margin -206.68%
Profit Margin -275.40%
FCF Margin -170.14%
ROA -62.40%
ROE -193.29%
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$2.00*
Low
2.00
Current: $0.423
High
2.00
Target: 2.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue3.723.602.761.892.312.824.875.356.004.95
Revenue Growth3.33%30.42%45.78%-18.01%-18.03%-42.17%-8.9%-10.91%21.32%-
Gross Profit0.761.000.590.10-0.300.782.592.502.992.25
Operating Income-9.82-7.61-8.23-7.65-14.49-23.70-15.07-17.55-13.73-3.22
Net Income-10.04-7.24-8.44-8.46-15.59-25.10-29.26-17.60-14.67-3.42
Shares Outstanding2.090.460.01-------
Earnings Per Share-4.80-16.67-1,749.00-10,386.00-97,742.39-310,203.01-608,155.41-455,022.75-415,645.78-122,506.13
Operating Cash Flow-9.81-7.61-8.13-7.50-11.60-19.36-10.30-8.58-6.00-2.71
Capital Expenditures-0.28-0.07-0.26-0.05-0.02-0.13-0.20-0.28-0.10-0.08
Free Cash Flow-10.09-7.67-8.39-7.54-11.61-19.50-10.50-8.86-6.10-2.79
Cash & Equivalents5.519.383.717.523.266.3014.9110.325.190.89
Total Debt0.65--2.685.258.90-5.020.091.49
Net Cash / Debt4.869.383.714.84-1.99-2.6014.915.305.09-0.61
Assets9.8812.296.119.415.6911.4620.7516.0110.474.36
Liabilities4.503.533.115.378.6414.254.6410.633.715.27
Book Value5.388.762.734.05-2.95-2.7916.105.396.75-0.91
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name InspireMD Inc.
Country Israel
Employees 48
CEO Marvin L. Slosman

Stock Information

Ticker Symbol NSPR
Stock Exchange NYSE American
Sector Healthcare
Industry Medical Devices
Unique Identifier NYSEAMERICAN: NSPR

Description

InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of coronary and vascular diseases. The company offers CGuard carotid embolic prevention systems for use in carotid artery applications; and MGuard prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions. It is also developing NGuard, a neurovascular flow diverter that diverts blood flow away from cerebral aneurysms in order to seal the aneurysms. InspireMD, Inc. distributes its products in Europe, Latin America, the Middle East, and Asia. The company is headquartered in Tel Aviv, Israel.